Sponsor:
Mount Sinai Hospital, Canada
Code:
NCT01270776
Conditions
Anti-infecting Agents, Local
Eligibility Criteria
Sex: All
Age: 0
Healthy Volunteers: Not accepted
Interventions
2% aqueous chlorhexidine
2% Chlorhexidine 70% isopropyl alcohol
Brief summary:
Conditions
Anti-infecting Agents, Local
Study ID
NCT01270776
Start date
Jan, 2011
Status verified date
May, 2013
Completion date
Jan, 2014
Anticipated
Primary completion date
Jan, 2014
Anticipated
Eligibility Criteria
Sex: All
Age: 0
Healthy Volunteers: Not accepted
Enrollment
462 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Aqueous Chlorhexidine
active comparator: 2% Chlorhexidine 70% isopropyl alcohol
Interventions
2% aqueous chlorhexidine
2% Chlorhexidine 70% isopropyl alcohol
Primary outcome measure
Central contacts
Locations
Mount Sinai Hospital
Recruiting
Toronto, Ontario, Canada, M5G 1X5
Contacts
Principal Investigator:
Vibhuti Shah, MD MRCP
Sponsor
Mount Sinai Hospital, Canada
Last update posted
May 14, 2013
Last verified
May, 2013
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Mount Sinai Hospital, Canada on 2013-05-14.